Sinclair Pharma PLC Notice of Results (7220H)
August 22 2016 - 2:00AM
UK Regulatory
TIDMSPH
RNS Number : 7220H
Sinclair Pharma PLC
22 August 2016
Sinclair Pharma plc
Notice of Results
London, 22 August 2016 - Sinclair Pharma plc (AIM: SPH.L)
("Sinclair" or "the Group"), the international company operating in
the fast growing global aesthetics market, will announce its
results for the six month period covering 1 January 2016 to 30 June
2016 on Wednesday 21 September 2016.
As previously announced, fully audited 18 month final results
for the period 1 July 2015 to 31 December 2016 will be published in
March 2017.
A briefing for analysts will be held at 09.30 BST at the offices
of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A
4HD. A live audio webcast and slide presentation will also be
available after the event at www.sinclairpharma.com.
-Ends-
For further information, please contact:
Sinclair Pharma plc Tel: +44 (0) 20 7467 6920
Chris Spooner/Alan Olby
Peel Hunt LLP Tel: +44 (0) 20 7418 8900
James Steel/Oliver Jackson
FTI Consulting Tel: +44 (0) 20 3727 1000
Ben Atwell/Brett Pollard
About Sinclair Pharma plc
Sinclair Pharma plc is an international company that operates in
the fast growth, high gross margin, global aesthetics market.
Sinclair has built a strong portfolio of differentiated,
complementary aesthetics technologies, which are experiencing
significant growth, targeting unmet clinical needs for effective,
high quality, longer duration, natural looking and
minimally-invasive treatments.
The Company is planning entry to multiple new geographic markets
and line extension launches over the next few years. The group has
an established sales and marketing presence in the leading EU
markets' and a rapidly growing International division concentrated
on the Emerging Markets through long term multi-product,
multi-country, sales, marketing and distribution deals with key
strategic partners.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORBLGDILGBBGLC
(END) Dow Jones Newswires
August 22, 2016 02:00 ET (06:00 GMT)
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From Apr 2024 to May 2024
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From May 2023 to May 2024